DHR vs KO: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and The Coca-Cola Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
The Coca-Cola Company · Consumer Defensive
$78.19
-7.8% upside to fair value
Grade D
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+13.2%).
KO trades at a lower forward P/E
(24.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
KO |
| Current Price |
$174.04 |
$78.19 |
| Fair Value Estimate |
$197.01 |
$72.12 |
| Upside to Fair Value |
+13.2%
|
-7.8%
|
| Market Cap |
$123.2B |
$336.5B |
| Forward P/E |
33.4x
|
24.6x
|
| EV / EBITDA |
20.3x
|
19.9x
|
| Price / Sales |
5.0x
|
6.8x
|
| Price / FCF |
23.3x
|
26.8x
|
| Revenue Growth YoY |
+3.7%
|
+12.1%
|
| Gross Margin |
60.7%
|
61.7%
|
| Operating Margin |
21.0%
|
29.3%
|
| Return on Equity |
7.1%
|
43.6%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
3.73%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
The Coca-Cola Company is a leading global beverage company specializing in non-alcoholic drinks with a diversified portfolio including sparkling soft drinks, juices, water, coffee, and energy beverages. The business quality is high due to its durable brand moat, consistent earnings growth, and strong operational efficiency, reflected in a 43.6% return on equity and 12.1% revenue growth in the mos…
Accumulation Zones
| Metric |
DHR |
KO |
| Zone Low |
$147.76 |
$54.09 |
| Zone High |
$167.46 |
$61.30 |
| In Buy Zone? |
No
|
No
|